|
| Exchange Received Time 07/10/2019 15:13:52 Exchange Disseminated Time 07/10/2019 15:13:59 Time Taken 00:00:07 | Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company's facility located at M.I.D.C, Ambernath (East), Thane-District.
We are enclosing a copy of the press release.
This is for your information and record. |
|
|